SCHEMBL4492986

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL4504865	0.85	PTGDR2 (1.00)	PTGDR2
	SCHEMBL4506517	0.85	PTGDR2 (1.00)	PTGDR2CCR2
	SCHEMBL4506990	0.84	PTGDR2 (1.00)	PTGDR2
	SCHEMBL4502515	0.83	PTGDR2 (1.00)	PTGDR2
	SCHEMBL4502046	0.83	PTGDR2 (1.00)	PTGDR2
	SCHEMBL4498145	0.83	PTGDR2 (0.81)	PTGDR2
	SCHEMBL4496289	0.81	PTGDR2 (0.55)	PTGDR2CCR1CCR2
	SCHEMBL1011409	0.78	PTGDR2 (0.58)	PTGDR2CCR1CCR2KCNQ3KCNQ2
	SCHEMBL4512565	0.78	PTGDR2 (0.48)	PTGDR2CCR1CCR2IDH2
	SCHEMBL10507700	0.77	FFAR1 (0.62)	PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.